|By PR Newswire||
|July 30, 2014 01:00 PM EDT||
WAYNE, Pa., July 30, 2014 /PRNewswire/ -- Ryan & Maniskas, LLP has commenced an investigation into potential securities law violations by certain officers of Galectin Therapeutics, Inc. ("Galectin" or the "Company") (NASDAQ: GALT).
Galectin shareholders who purchased Galectin shares should contact Richard A. Maniskas, Esquire at 877-316-3218 or at [email protected] to learn more about this investigation or visit: www.rmclasslaw.com/cases/galt.
Galectin, a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The investigation relates to the publication of a July 28, 2014, article that disclosed that the Company had hired a stock promotions firm to tout its securities. The investigation also relates to the Company's July 29, 2014, disclosure that its experimental drug GR-MD-02, which was being developed for the treatment of fatty liver disease, showed little difference from a placebo in its Phase 1 study. On this news, shares of Galectin declined $8.84 per share, or 60.80%, to close on July 29, 2014, at $5.70 per share, on unusually heavy volume.
If you own Galectin shares and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free: (877) 316-3218 or visit: www.rmclasslaw.com/cases/galt. You may also email Mr. Maniskas at [email protected]. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.
Ryan & Maniskas, LLP
Richard A. Maniskas, Esquire
995 Old Eagle School Rd., Suite 311
Wayne, PA 19087
SOURCE Ryan & Maniskas, LLP
Large scale deployments present unique planning challenges, system commissioning hurdles between IT and OT and demand careful system hand-off orchestration. In his session at @ThingsExpo, Jeff Smith, Senior Director and a founding member of Incenergy, will discuss some of the key tactics to ensure delivery success based on his experience of the last two years deploying Industrial IoT systems across four continents.
Jul. 28, 2016 03:00 AM EDT Reads: 1,587
Jul. 28, 2016 02:30 AM EDT Reads: 1,782
Jul. 28, 2016 02:30 AM EDT Reads: 1,526
Jul. 28, 2016 02:15 AM EDT Reads: 1,390
Jul. 28, 2016 02:00 AM EDT Reads: 2,043
Jul. 28, 2016 01:45 AM EDT Reads: 1,101
Jul. 28, 2016 01:15 AM EDT Reads: 826
Jul. 28, 2016 01:00 AM EDT Reads: 1,615
Jul. 28, 2016 12:15 AM EDT Reads: 2,234
Jul. 27, 2016 10:30 PM EDT Reads: 1,154
Jul. 27, 2016 10:30 PM EDT Reads: 1,408
Jul. 27, 2016 10:30 PM EDT Reads: 2,014
Jul. 27, 2016 10:15 PM EDT Reads: 1,407
Jul. 27, 2016 10:00 PM EDT Reads: 2,665
Jul. 27, 2016 09:45 PM EDT Reads: 2,005